Novel TSC2 Mutations and Decreased Expression of Tuberin in Cultured Tumor Cells with an Insertion Mutation

被引:5
|
作者
Feng, Jian-Hua [1 ,2 ]
Yamamoto, Toshiyuki [3 ]
Nanba, Eiji [3 ]
Ninomiya, Haruaki [4 ]
Oka, Akira [2 ]
Ohno, Kousaku [2 ]
机构
[1] Zhejiang Univ, Children Hosp, Dept Child Neurol, Hangzhou 310003, Zhejiang, Peoples R China
[2] Tottori Univ, Fac Med, Inst Neurol Sci, Div Child Neurol, Yonago, Tottori 683, Japan
[3] Tottori Univ, Gene Res Ctr, Yonago, Tottori, Japan
[4] Tottori Univ, Fac Med, Sch Life Sci, Dept Neurobiol, Yonago, Tottori 683, Japan
关键词
giant cell astrocytoma; Japanese; mutation; TSC2; tuberin; tuberous sclerosis complex;
D O I
10.1002/humu.9225
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by hamartomas in many organs. Two genes responsible for TSC, TSC1 and TSC2, were recently identified. TSC1 and TSC2 encode the proteins hamartin and tuberin, respectively, and 337 different mutations have been reported in these genes thus far. Here, we report six novel TSC2 mutations including one missense mutation, two nonsense point mutations, two frameshifts, and an insertion mutation. The insertion mutation is unique because of its location at an exon/intron boundary that results in triplication of a 34-bp sequence. Cultured tumor cells from the patient with this insertion mutation exhibited a decreased level of tuberin as revealed by Western blotting, suggesting that the mRNA of TSC2 is not translated as efficiently or the translated protein exhibits reduced stability. Five novel polymorphisms of TSC2 were also identified. As previously reported, the missense mutations were located in the GTPase activating protein-related domain of TSC2 encoded in exons 34-38. No TSC1 mutations were identified in the present subjects. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin
    Hodges, AK
    Li, SW
    Maynard, J
    Parry, L
    Braverman, R
    Cheadle, JP
    DeClue, JE
    Sampson, JR
    HUMAN MOLECULAR GENETICS, 2001, 10 (25) : 2899 - 2905
  • [2] Tumor Suppressor Tuberin (TSC2) Negatively Regulates the Expression of Sphingolipid Metabolism Genes and Functions
    Yu, J. J.
    Zhang, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex
    Nellist, M
    Verhaaf, B
    Goedbloed, MA
    Reuser, AJJ
    van den Ouweland, AMW
    Halley, DJJ
    HUMAN MOLECULAR GENETICS, 2001, 10 (25) : 2889 - 2898
  • [4] Tuberin (TSC2) and hamartin (TSC1) expression in human fetal and child brains
    Park, SH
    Emelin, J
    Vinters, HV
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05): : 515 - 515
  • [5] Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis
    Kolb, TM
    Duan, L
    Davis, MA
    TOXICOLOGICAL SCIENCES, 2005, 88 (02) : 331 - 339
  • [6] Novel phosphatase for tumor suppressor TSC2?
    Malanchuk, O. M.
    Palchevskyy, S. S.
    Filonenko, V. V.
    FEBS JOURNAL, 2011, 278 : 465 - 465
  • [7] Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2
    Ikeda, Yoshihiko
    Taveira-DaSilva, Angelo M.
    Pacheco-Rodriguez, Gustavo
    Steagall, Wendy K.
    El-Chemaly, Souheil
    Gochuico, Bernadette R.
    May, Rose M.
    Hathaway, Olanda M.
    Li, Shaowei
    Wang, Ji-an
    Darling, Thomas N.
    Stylianou, Mario
    Moss, Joel
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2011, 300 (01) : L64 - L72
  • [8] A novel TSC2 mutation causing tuberless tuberous sclerosis
    Giannantoni, Nadia Mariagrazia
    Restuccia, Domenico
    Della Marca, Giacomo
    Alfano, Rosa Maria
    Vollono, Catello
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2014, 23 (07): : 580 - 582
  • [9] Chemokine-Enhanced Chemotaxis of Lymphangioleiomyomatosis Cells with Mutations in the Tumor Suppressor TSC2 Gene
    Pacheco-Rodriguez, Gustavo
    Kumaki, Fumiyuki
    Steagall, Wendy K.
    Zhang, Yi
    Ikeda, Yoshihiko
    Lin, Jing-Ping
    Billings, Eric M.
    Moss, Joel
    JOURNAL OF IMMUNOLOGY, 2009, 182 (03): : 1270 - 1277
  • [10] Neoplastic cells purified from tuberous sclerosis skin tumors show loss of tuberin function through biallelic mutations in TSC2
    Wang, J
    Crooks, D
    Takeuchi, F
    Li, S
    Pacheco-Rodriguez, G
    Moss, J
    Darling, TN
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A19 - A19